Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel–Lindau disease

Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel–Lindau disease

Background The effect of microwave ablation (MWA) for the renal cell carcinoma (RCC) in Von Hippel-Lindau (VHL) disease is unclear.Objective To assess the safety, Technique efficacy, renal function and oncological outcome of MWA for RCC in VHL patients.Methods Consecutive patients with RCCs in VHL d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiye Chen, Lin Zheng, Wei Zhang, Zhen Wang, Jie Yu, Ping Liang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	International Journal of Hyperthermia
Subjects:	Microwave ablation renal cell carcinoma overall survival von Hippel–Lindau (VHL) disease
Online Access:	https://www.tandfonline.com/doi/10.1080/02656736.2024.2308079
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pathogenicity of germline VHL variants is associated with renal cell carcinoma size in von Hippel-Lindau disease
by: Gustavo H. Mori, et al.
Published: (2025-02-01)

Introducción de la técnica PCR-RFLP para el diagnóstico de dos mutaciones en el gen VHL
by: Antonio Alejandro Esperón, et al.
Published: (2013-07-01)

Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
by: Olivia Kola, et al.
Published: (2025-01-01)

Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors
by: Li Liu, et al.
Published: (2024-12-01)

Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC
by: Jing Zhang, et al.
Published: (2024-12-01)

Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study
by: Qian Cai, et al.
Published: (2024-12-01)

A prediction model for guiding tumor microwave ablation surgery based on simulation
by: Lu Qian, et al.
Published: (2025-01-01)

Directional microwave ablation in spine: experimental assessment of computational modeling
by: Austin Pfannenstiel, et al.
Published: (2024-12-01)

Ultrasound-guided percutaneous microwave ablation of primary hyperthyroidism: security and efficacy analysis
by: Jing-E Zhu, et al.
Published: (2024-12-01)

Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers
by: Min Zhuang, et al.
Published: (2024-12-01)

Complications of microwave ablation in patients with persistent/recurrent hyperparathyroidism after surgical or ablative treatment
by: Ying Wei, et al.
Published: (2024-12-01)

Computed tomography-guided microwave ablation therapy for pediatric adrenal neuroblastoma with lung nodule a case report
by: Shu-Cong Peng, et al.
Published: (2025-01-01)

Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma
by: Young Mi Hong
Published: (2024-12-01)

Safety assessment of microwave ablation in sheep vertebral bodies
by: Hendricus Nijland, et al.
Published: (2024-12-01)

Impact of thyrotropin levels on outcomes in T1N0M0 papillary thyroid cancer after microwave ablation
by: Ying Wei, et al.
Published: (2024-12-01)

Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non‐Small Cell Lung Cancer Treated With Microwave Ablation
by: Lin Cheng, et al.
Published: (2025-01-01)

Comparison of the efficacy and safety of ultrasound-guided radiofrequency ablation and microwave ablation for the treatment of unifocal papillary thyroid microcarcinoma: a retrospective study
by: Ning Li, et al.
Published: (2024-12-01)

Ni virtuosas ni ciudadanas: inconsistencias prácticas en la teoría de Kant
by: Concha Roldán
Published: (2013-01-01)

Risk factors for symptom recurrence after microwave ablation of adenomyosis: a preliminary retrospective study
by: Sainan Guan, et al.
Published: (2024-12-01)

Percutaneous microwave ablation, perfusion, and reconstruction combined with a synthetic bone substitute in symptomatic bone cysts: a minimum of 26 months follow-up
by: Wenhan Huang, et al.
Published: (2024-12-01)

Hydrodissection technique for pain relief during peri-microwave ablation in patients with subpleural non-small cell lung cancers
by: Nan Wang, et al.
Published: (2024-12-01)

Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans.
by: Tammie Bishop, et al.
Published: (2004-10-01)

Bilateral Pheochromocytomas in a Patient with Y175C Von Hippel-Lindau Mutation
by: Olga Astapova, et al.
Published: (2018-01-01)

The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
by: Wenhui Wang, et al.
Published: (2025-01-01)

Assessment of thermal ablation for treating Bethesda IV thyroid nodules: a systematic review and meta-analysis
by: Jia-shan Yao, et al.
Published: (2025-01-01)

Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast Administration
by: Anne Bettina Beeskow, et al.
Published: (2025-01-01)

Electromagnetic navigation system for computed tomography-guided synchronous percutaneous lung biopsy and microwave ablation of pulmonary nodules: a prospective, single-center, single-arm clinical study
by: Shengwei Li, et al.
Published: (2024-12-01)

Efficacy and safety of microwave ablation for treatment of follicular thyroid neoplasms: a preliminary study
by: Xin-Yi Zhou, et al.
Published: (2024-12-01)

Molecular Imaging of Hypoxia-Inducible Factor 1α and von Hippel-Lindau Interaction in Mice
by: Clara Y.H. Choi, et al.
Published: (2008-05-01)

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01)

Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
by: Yanting Hu, et al.
Published: (2024-12-01)

Graves’ disease diagnosed nearly six months after microwave ablation of benign thyroid nodules: a case report
by: Yunru Gu, et al.
Published: (2025-01-01)

TGF-β1 inhibitor enhances the therapeutic effect of microwave ablation on hepatocellular carcinoma
by: Shufang Xiang, et al.
Published: (2024-12-01)

ｖｏｎＨｉｐｐｅｌ－Ｌｉｎｄａｕ病伴视网膜毛细血管瘤的长期随访
Published: (2014-01-01)

Ultrasound-guided microwave ablation versus surgery for low-risk solitary papillary thyroid microcarcinoma: a propensity-matched cohort study
by: Yujie Ren, et al.
Published: (2025-01-01)

Ultrasound-guided percutaneous microwave ablation for metabolic-associated fatty liver disease-related hepatocellular carcinoma (HCC) versus hepatitis virus B-related HCC: a propensity score matching study
by: Yannan Qiao, et al.
Published: (2024-12-01)

Changes in liver and kidney function, red blood cell count and hemoglobin levels 1 day after ultrasound-guided percutaneous microwave ablation for uterine fibroids
by: Xiao-Yu Huang, et al.
Published: (2024-12-01)

Safety and efficacy of indocyanine green fluorescence imaging for real-time guidance of laparoscopic thermal ablation in patients with liver cancer
by: Qitao Hu, et al.
Published: (2024-12-01)

Simulation of Image-Guided Microwave Ablation Therapy Using a Digital Twin Computational Model
by: Frankangel Servin, et al.
Published: (2024-01-01)

Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report
by: Jie Tan, et al.
Published: (2024-12-01)